• About us
• Contact

Advertisement

Organisation › Details

BioDiscovery 4 Fund (Edmond de Rothschild Investment Partners)

Over the past 20 years, Andera Partners has established itself as one of Europe’s leading private capital investment firms. Its teams manage €4.3 billion in investments in several areas, including life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion/Croissance, Andera Co-Invest), sponsorless mezzanine financing (Andera Acto) and infrastructure supporting the energy and ecological transition (Andera Infra). Andera Partners’ mission is to support companies and their managers to facilitate strong and sustainable growth. The high level of our firm performance offered to our investors relies on strong partnerships and shared values between entrepreneurs in our portfolio companies and our internal teams. Performance through collective engagement, the “Power of And”, is what defines Andera Partners’ DNA. Based in Paris, with offices in Antwerp, Madrid, Milan and Munich, Andera Partners is wholly owned by its teams, which include 115 professionals, 72 of which are dedicated investment professionals. It is structured as a partnership and managed by a board of 13 partners. *

 

	Start	2012-07-10 closing, first
	Group	New York Life (Group)
	Predecessor	BioDiscovery 3 Fund (Edmond de Rothschild Investment Partners)
	Successor	BioDiscovery 5 Fund (Andera Partners / EdRIP)
	Industry	BioDiscovery 4 Fund (Edmond de Rothschild)
	Industry 2	BIOTECH
	Region	Paris
	Country	France
	City	n. a. Paris
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	125,000,000 (capital, paid-in 2012-07-10)
		* Document for »About Section«: Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid.
		Record changed: 2024-12-31

Advertisement

More documents for New York Life (Group)

• [1] Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels....
• [2] Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid....
• [3] SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich....
• [4] Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel....
• [5] Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin....
• [6] Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris....
• [7] Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris....
• [8] Andera Partners. (7/7/22). "Press Release: Andera Partners Strengthens Its Life Sciences Team with a New Partner"....
• [9] Mineralys Therapeutics, Inc.. (6/8/22). "Press Release: Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension". Philadeliphia, PA....
• [10] Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.